Loading...
XHEL
NANOFH
Market cap98mUSD
Dec 05, Last price  
0.99EUR
1D
0.00%
1Q
12.27%
IPO
-78.04%
Name

Nanoform Finland Oyj

Chart & Performance

D1W1MN
XHEL:NANOFH chart
P/E
P/S
30.47
EPS
Div Yield, %
Shrs. gr., 5y
16.33%
Rev. gr., 5y
124.14%
Revenues
3m
+8.22%
65,000235,00049,093686,7481,954,5473,487,3762,566,4852,777,502
Net income
-23m
L+12.87%
-521,273-2,074,286-7,692,510-19,441,308-19,689,659-22,074,848-20,755,874-23,427,927
CFO
-18m
L+1.53%
-669,177-1,503,890-5,797,759-14,156,141-14,348,642-20,079,696-18,000,973-18,275,872

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
IPO date
Jun 04, 2020
Employees
158
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT